07Sep 2021
The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels

The lncRNA ‘UCA1’ modulates the response to chemotherapy of ovarian cancer through direct binding to miR‐27a‐5p and control of UBE2N levels

UCA1 cytoplasmic short isoform is acting as a competing endogenous RNA for miR‐27a‐5p. Upon UCA1 down‐regulation, miR‐27a‐5p is no longer prevented to bind and downregulate its direct target UBE2N. UBE2N inhibition triggers BIM upregulation, which sensitizes cells and patient derived organoids to the cytotoxic action of platinum drugs.

  • #oncology

Like

Save

Share